Use of Catheters With the AgION Antimicrobial System in Kidney Transplant Recipients to Reduce Infection Risk

Transplantation Proceedings

Volumn 38, Issue 3, 2006, Pages 707-710

  Loertzer, H ^a,b   Soukup, J ^b   Hamza, A ^a   Wicht, A ^a   Rettkowski, O ^a   Koch, E ^a   Fornara, P ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; POLYURETHAN; SILVER DERIVATIVE;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BIOFILM; BLOOD CULTURE; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; FUNGUS; GRAFT RECIPIENT; HUMAN; INFECTION RISK; JUGULAR VEIN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROBIAL COLONIZATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

CATHETERIZATION, CENTRAL VENOUS; COMMUNICABLE DISEASE CONTROL; HUMANS; INCIDENCE; JUGULAR VEINS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; STAPHYLOCOCCAL INFECTIONS; SUBCLAVIAN VEIN;

EID: 33646088602     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.01.064     Document Type: Article

References (35)

1. Maki D.G., Stolz S.M., Wheeler S., et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127 (1997) 257
2. Goetz A.M., Wagener M.M., Miller J.M., et al. Risk of infection due to central venous catheters. effect of site of placement and catheter type. Infect Control Hosp Epidemiol 19 (1998) 842
3. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. JAMA 281 (1999) 261
4. Bong J.J., Kite P., Wilco M.H., et al. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters. a randomised controlled trial. J Clin Pathol 56 (2003) 731
5. Ranucci M., Isgro G., Giomarelli P.P., et al., Catheter Related Infection Trial (CRIT) Group. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 31 (2003) 52
6. McConnell S.A., Gubbins P.O., and Anaissie E.J. Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash. Clin Infect Dis 39 (2004) 1829
7. Marciante K.D., Veenstra D.L., Lipsky B.A., et al. Which antimicrobial impregnated central venous catheter should we use? Modelling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 31 (2003) 1
8. Dezfulian C., Lavelle J., Nallamothu B.K., et al. Rates of infection for single-lumen versus multilumen central venous catheters. a meta-analysis. Crit Care Med 31 (2003) 2385
9. Arnow P.M., Quimosing E.M., and Beach M. Consequence of intravascular catheter sepsis. Clin Infect Dis 16 (1993) 778
10. Pittet D., Tarara D., and Wenzel R. Nosocomial bloodstream infection in critically ill patients. excess length of stay, extra costs, and attributable mortality. JAMA 271 (1994) 1598
11. Collignon P.J. Intravascular catheter associated sepsis. a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J 161 (1994) 374
12. Digiovine B., Chenoweth C., Watts C., et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160 (1999) 976
13. Rello J., Ochagavia A., Sabanes E., et al. Evaluation of outcome of intravenous catheter-related infection in critically ill patients. Am J Respir Crit Care Med 162 (2000) 1027
14. Sherertz R.J., Ely E.W., Westbrook D.M., et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 132 (2000) 641
15. Moretti E.W., Ofstead C.L., Kristy R.M., et al. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 61 (2005) 139
16. Fraenkel D.J., Rickard C., and Lipman J. Can we achieve consensus on central venous catheter-related infections?. Anaesth Intensive Care 28 (2000) 475
17. Trzeciak S., Sharer R., Piper D., et al. Infections and severe sepsis in solid-organ transplant patients admitted from a university-based ED. Am J Emerg Med 22 (2004) 530
18. Darouiche R.O., Berger D.H., Khardori N., et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters. a randomized controlled trial. Ann Surg 242 (2005) 193
19. Maki D.G. Infections caused by intravascular devices used for infusion therapy. pathogenesis prevention, and management (1994), Waldvogel FA ASM Pr, Bistro Al 155
20. Al-Khader A.A., and Shaheen F.A.M. Posttransplant complications encountered in renal transplantation in the Middle East. Transplant Proc 36 (2004) 180
21. Safdar N., and Maki D.G. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 30 (2002) 2632
22. Ljungman P., Hagglund H., Bjorkstrand B., et al. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters. a randomized, controlled study. Support Care Cancer 5 (1997) 485
23. Bach A. Prevention of infections caused by central venous catheters-established and novel measures. Infection 27 Suppl 1 (1999) 11
24. Pearson M.L. Committee HICPAC. guideline for the prevention of intravascular device related infections. Infect Control Hosp Epidemiol 17 (1996) 438
25. Smith R.L., Meixler S.M., and Simberkoff M.S. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100 (1991) 164
26. Scherhag Seifert L.M. Evaluation of in vivo adsorption of blood elements onto hydrogel coated silicone rubber by scanning electron microscopy and fourier transform infrared spectroscopy. J Biomed Mat Res 19 (1985) 1043
27. Bylock A. Surface morphology of unused and used Hydromer coated intravenous catheters. Scan Electron Microsc Pt1 (1986) 157
28. Guggenbichler J.P., Böswald M., Lugauer S., et al. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 27 Suppl 1 (1999) 16
29. Guggenbichler J.P. Central venous catheter associated infections. pathophysiology incidences clinical diagnosis and prevention-a review. Mat Wiss und Werkstofftechnik 34 (2003) 1145
30. Guggenbichler J.P., Juhl G., and Study Group Silver Catheter. Clinical investigation with a new silver impregnated central venous catheter. Hyg Med 28 (2003) 235
31. Guggenbichler J.P., Carbon R., Lugauer S., et al. Reduced incidence of catheter related infections in long term i.v. catheters in children by use of a silver impregnated catheter (2000), ECCMID, Stockholm
32. Vygon: Produktinformation: Antimikrobieller Katheter auf der Basis Zeolith.
33. Khare M.D., Bukhari S.S., Swann R.A., et al. Are silver-impregnated central vascular catheters superior to non-impregnated catheters? University Hospitals of Leicester NHS Trust, Leicester, United Kingdom (2004) 76 Paper presented at the 44th ICAAC Washington, DC
34. Darouiche R.O., Raad I.I., Heard S.O., et al. A comparison of two antimicrobial-impregnated central venous catheter. N Engl J Med 340 (1999) 1
35. Sadoyama G., and Filho P.P.G. Comparison between the jugular and subclavian vein as insertion site for central venous catheters. microbiological aspects and risk factors for colonization and infection. Braz Infect Dis 7 (2003) 142